NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Research Report: Maruti Suzuki

Key Findings

Maruti Suzuki India Limited (MSIL) has underperformed the Auto index in recent times, driven by near-term wholesale underperformance and disappointing 3Q performance. However, our analysis suggests that these concerns may be overstated.

Retail Demand and Capacity Constraints

Read also: Expert Portfolio Manager Raja Venkatraman Names Top Investment Picks for June 4

Despite near-term wholesale constraints, retail demand for MSIL remains healthy, with strong sales in both cars and utility vehicles (UVs). The company's outperformance in retail sales post-GST cut is a positive indicator. Additionally, MSIL's capacity constraints are expected to be alleviated from April 2026, as its new capacity comes online.

Launch Pipeline and Export Momentum

We expect MSIL to outperform industry growth in FY27, driven by a healthy launch pipeline, which includes a new Brezza variant, the recently launched Victoris and e-Vitara, and at least one more new launch in FY27E. The company's export momentum is also expected to remain healthy, with a medium-term target of 750,000-800,000 vehicles by FY31. MSIL has already surpassed its FY26 export target in February 2026.

Outlook and Valuation

Read also: MarketSmith India's 4 June Stock Recommendations

We forecast a 16% earnings compound annual growth rate (CAGR) for MSIL over FY25-28E. Based on this outlook, we reiterate our BUY rating on MSIL with a target price of INR 17,406, valued at 26x December 2027 earnings per share (EPS).

Investor Takeaway

Investors should consider Maruti Suzuki's potential for growth driven by healthy retail demand and upcoming new capacity.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.